Commitment Commencement Date. Closing Date. Commitment Termination Date: the close of the Business Day following the Closing Date. Credit Extension Amount on the Closing Date: $20,000,000. Permitted Purpose: Not applicable Credit Facility #2: Credit Facility and Type: Term, Tranche 2 MidCap Financial Trust Thirty Million Dollars ($30,000,000) Total: Thirty Million Dollars ($30,000,000)
Appears in 1 contract
Sources: Credit and Security Agreement (Biocryst Pharmaceuticals Inc)
Commitment Commencement Date. Closing Date. Commitment Termination Date: the close of the Business Day following the Closing Date. Minimum Credit Extension Amount on the Closing DateAmount: $20,000,000. Permitted Purpose: Not applicable Credit Facility #2: Credit Facility and Type: Term, Tranche 2 MidCap Financial Trust Thirty Million Dollars ($30,000,000) Total: Thirty Million Dollars ($30,000,000)12,000,000
Appears in 1 contract
Sources: Credit, Security and Guaranty Agreement (Cardiome Pharma Corp)
Commitment Commencement Date. Closing Date. Commitment Termination Date: the close of the Business Day following the Closing Date. Minimum Credit Extension Amount on the Closing DateAmount: $20,000,000. 30,000,000.00 Permitted Purpose: Not applicable N/A Lenders for and their respective Applicable Commitments to this Credit Facility #2Facility: Credit Facility and Type: Term, Tranche 2 MidCap Financial Trust Thirty Lender Applicable Commitment Total Forty Million Dollars ($30,000,00040,000,000.00) TotalThe following defined terms apply to this Credit Facility: Thirty Million Dollars ($30,000,000)Applicable Funding Conditions:
Appears in 1 contract
Sources: Credit, Guaranty and Security Agreement (Gossamer Bio, Inc.)